91 – 100 of 203
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
(
- Contribution to journal › Article
-
Mark
The European Vasculitis Society 2016 Meeting Report
(
- Contribution to journal › Article
-
Mark
Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis
(
- Contribution to journal › Article
- 2016
-
Mark
Home- or Institutional Hemodialysis? - a Matched Pair-Cohort Study Comparing Survival and Some Modifiable Factors Related to Survival
(
- Contribution to journal › Article
-
Mark
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Comorbidities in patients with antineutrophil cytoplasmic antibody-associated vasculitis versus the general population
(
- Contribution to journal › Article
-
Mark
IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period
(
- Contribution to journal › Article